An earlier study suggested that galectin-3 might form a bridge between MUC1 and EGFR in cancer cells.43 In our study, very minimal galectin-3 was co-immunoprecipitated with EGFR and addition of exogenous galectin-3 also showed no effect on EGFR association with galectin-3 (Figure 7f). Here, LGALS3 is linked to cancer.